3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Prostatic Neoplasms
4
Endometrial Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Retinoblastoma
1
Peritoneal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Mouth Neoplasms
1
Interventions
Vincristine
3
Etoposide
3
Carboplatin
3
Cyclophosphamide
2
trioctyl phosphine oxide
1
pembrolizumab
1
pegfilgrastim
1
Topotecan
1
Thiotepa
1
Surveys and Questionnaires
1
Platinum Compounds
1
Observation
1
Mesna
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eye Enucleation
1
Drug Therapy
1
Doxorubicin
1
Cytapheresis
1
Cryotherapy
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Retinoblastoma
×
Observation
×
Clear all
NCT02870907
2026-01-07
RB SFCE 09
Institut Curie
Phase 2
Active not recruiting
195 enrolled